Download presentation
Presentation is loading. Please wait.
Published byBarrie Curtis Modified over 9 years ago
1
Secondary Hypertension: Adrenal and Nervous Systems Ανδρέας Πιτταράς Καρδιολόγος Καρδιολόγος Clinical Hypertension Specialist ESH Υπερτασικό ιατρείο Τζάνειο νοσοκομείο Υπερηχοκαρδιογραφικό εργαστήριο ΝΜΥΑ ΙΚΑ
2
Adrenocortical Causes of Hypertension
3
The adrenal cortex can cause hypertension
4
Pathways of adrenal steroidogenesis
5
Algorithmic approach to mineralocorticoid-induced hypertension
6
Hypertensive Syndromes Secondary to Hypersecretion of Deoxycorticosterone
7
Abnormalities of steroid production
8
Findings on physical examination
9
17 -hydroxylase deficiency syndrome
10
Physical characteristics
11
Hypertensive Syndromes Secondary to Cortisol Excess
12
Causes of Cushing's syndrome
13
Abdominal striae caused by excess cortisol production
14
Ectopic adrenocorticotropic hormone excess
16
Inferior petrosal sinus sampling for ACTH
17
Inferior petrosal sinuses before and after oCRH
18
OHSD deficiency syndromes
19
Hypertensive Syndromes Secondary to Hypersecretion of Aldosterone
20
Primary aldosteronism
21
Clinical clues to the presence of primary aldosteronism Spontaneous hypokalemia Diuretic-induced hypokalemia Difficulty in maintaining a normal serum potassium while on diuretics despite concomitant use of potassium-sparing agents or KCl supplementation Refractory hypertension Family history of primary aldosteronism Primary aldosteronism can occur at all ages
22
Serum potassium concentrations in primary aldosteronism
23
Stimulated plasma renin activity in primary aldosteronism
24
Aldosterone excretion rate
25
Plasma aldosterone concentration
26
Sensitivity and specificity of screening tests
27
Biochemical confirmation of adenoma versus hyperplasia MEASUREMENTS ADENOMA BILATERAL HYPERPLASIA Serum potassium, mEq/L 3.0 3.0 Plasma 18-OHB, ng/dL 100 100 Plasma aldosterone response to ambulation Decrease Increase Urinary 18-hydroxycortisol Increase Normal
28
CT scan of normal adrenal glands
29
CT scan of a right adrenal tumor
31
Venography of a left adrenal tumor
32
Diagnostic accuracy of imaging techniques in adrenocortical disorders TRUE POSITIVES, % DISORDER PATIENTS, n NP-59 CT Cushing's syndrom 28 93 90 Primary aldosteronis 58 88 91 Nonfunctional tumors 13 100 89 Diagnostic accuracy of iodocholesterol NP-59 scanning
34
Hemodynamic features of primary aldosteronism
35
Diuretic therapy in patients with primary aldosteronism
36
Relationship between plasma volume and arterial BP
37
Calcium antagonists as alternatives to diuretics
38
Surgery is indicated in patients with solitary adenomas
39
Influence of the severity of hypertension on BP response after surgery
40
Efficacy of long-term medical management of aldosterone- producing adenomas ELECTROLYTE LEVELS AT DIAGNOSIS ELECTROLYTE LEVELS AT LAST FOLLOW-UP PATIENT AGE y SEX FOLLOW-UP, y BLOOD PRESSURE AT PRESENTATION *, mm Hg MOST RECENT BLOOD PRESSURE *, mm Hg SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE 1 65 M 5 170/94 120/80 145 3.1 105 30 140 5.2 110 28 2 69 M 12 164/65 157/86 141 3.2 98 35 141 3.9 104 30 3 63 M 11 178/96 130/95 141 2.9 100 28 144 4.0 107 26 4 43 F 8 180/104 124/82 140 3.0 98 31 137 4.1 105 25 5 39 F 5 184/132 128/80 141 3.9 102 29 140 3.7 106 28 6 76 M 9 174/100 116/74 143 2.9 104 29 139 4.7 103 23 7 68 M 6 180/105 195/76 140 3.1 98 32 142 4.2 109 28 8 69 M 5 190/95 130/70 144 2.9 103 29 140 4.1 104 21 9 59 M 7 180/116 145/99 144 2.4 102 35 139 4.3 104 30 10 55 M 8 180/110 140/74 145 3.0 102 30 142 4.6 104 30 11 59 M 6 165/102 112/68 142 3.0 106 30 142 4.8 108 30 12 50 M 6 177/117 115/80 144 3.1 102 31 143 4.5 104 27 13 44 M 6 160/110 130/82 141 3.0 106 29 140 4.3 103 29 14 54 F 8 160/98 142/60 144 3.4 106 29 142 4.7 108 25 15 52 F 13 150/104 104/76 142 3.3 105 24 137 4.4 106 25 16 52 F 5 168/102 128/91 143 2.7 102 32 141 3.6 106 32 17 54 F 17 180/110 101/71 143 3.0 105 33 139 4.4 101 30 18 59 M 8 176/116 158/78 142 2.6 106 29 138 4.6 101 27 19 44 F 9 190/122 122/78 142 2.6 98 32 137 3.6 98 26 20 61 F 14 160/110 144/72 145 2.9 103 35 140 3.7 113 29 21 68 F 5 166/108 111/78 143 2.6 103 30 146 4.5 108 26 22 66 M 11 178/108 150/92 141 3.0 101 31 142 3.8 102 26 23 73 M 10 178/100 107/66 143 3.8 99 31 143 4.8 105 24 56 M 15 200/125 128/85 141 3.2 102 32 139 4.6 102 26 * Blood pressure values are the average of at least three measurements. Levels are measured in millimoles per liter.
41
Comparison of eplerenone and spironolactone
42
Glucocorticoid-remediable aldosteronism
43
Pheochromocytoma
44
Important facts about pheochromocytomas About 30% of pheochromocytomas reported in the literature are found either at autopsy or at surgery for an unrelated problem 35% to 76% of pheochromocytomas discovered at autopsy are clinically unsuspected during life The average age of diagnosis in those whose disease was discovered before death was 48.5 y, while the average in those diagnosed at autopsy was 65.8 y Death was usually attributed to cardiovascular complications
45
Pathologic features of pheochromocytoma
46
-Adrenergic hyperresponsiveness Acute state of anxiety Angina pectoris Acute infections Autonomic epilepsy Hyperthyroidism Idiopathic orthostatic hypotension Cerebellopontine angle tumors Acute hypoglycemia Acute drug withdrawal (Clonidine - Adrenergic blockade -Methyldopa Alcohol) Vasodilator therapy (Hydralazine, Minoxidil) Factitious administration of sympathomimetic agents Tyramine ingestion in patients on monoamine oxidase inhibitors Menopausal syndrome with migraine headaches Differential diagnosis of pheochromocytoma
47
Priorities for detection of pheochromocytoma Patients with the triad of episodic headaches, tachycardia, and diaphoresis (with or without associated hypertension) Family history of pheochromocytoma Incidental suprarenal masses Patients with a multiple endocrine adenomatosis syndrome, neurofibromatosis, or von Hippel-Lindau disease Adverse cardiovascular responses to anesthesia, to any surgical procedure, or to certain drugs (eg, guanethidine, tricyclics, thyrotropin-releasing hormone, naloxone, or antidopaminergic agents)
48
Supine resting plasma catecholamines
49
Relationship between BP and plasma catecholamines
50
Effect of clonidine on BP
51
Clonidine suppression test in pheochromocytoma
52
Glucagon stimulation test for pheochromocytoma
53
Urinary normetanephrine values
54
Comparison of indexes of catecholamine production
55
Sensitivity and specificity of tests for pheochromocytoma
56
Three modalities used to localize pheochromocytomas
60
Diagnostic strategies in pheochromocytoma
61
Medical management of pheochromocytoma
62
Perioperative hemodynamic variables OPEN, n=20 LAPAROSCOPIC, n=14 P VALUE Mean preoperative blood pressure *, mm Hg 140 18/78 10 144 13/74 14 0.50 Highest blood pressure *, mm Hg 191 33/98 25 194 19/106 19 0.50 Hypertension 0.5 (0 5) 1.0 (0 3) 0.41 SBP 200 mm Hg 0 (0 4) 0 (0 2) 0.70 Lowest blood pressure *, mm Hg 88 14/50 13 98 19/57 8 0.05 Hypotension 2.0 (0 6) 0 (0 2) 0.005 Highest heart rate, bpm 104 15 101 24 0.78 Heart rate 110 bpm 0 (0 3) 0 (0 3) 0.36 Lowest heart rate, bpm 61 11 60 9 0.81 Heart rate 50 bpm 0 (0 1) 0 (0 5) 0.81 Patients requiring treatment for hypertension ‡, n 17.0 13.0 0.63 Patients requiring treatment for hypotension, n 9.0 1.0 0.02 * Systolic and diastolic blood pressure presented as the standard deviation; P value based on the test. Median number of episodes for one patient, with the range in parentheses; P value based on the Jackson-Whitney U test. ‡ Includes patients who intraoperatively received at least one of the following treatments: nitroglycerin, sodium nitroprusside, -blocker, / -blocker, or a calcium channel antagonist. Includes patients who intraoperatively received at least one of the following treatments: phenylephrine, dopamine, or epinephrine.
63
Blood pressure response to calcium antagonists
64
References
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.